United Services Automobile Association Innoviva, Inc. Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$10.05 - $14.55 $199,402 - $288,686	-19,841 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$13.1 - $14.95 $19,728 - $22,514	1,506 Added 8.21%	19,841 $289,000
Q1 2019 May 13, 2019	BUY	$13.69 - $20.06 $110,409 - $161,783	8,065 Added 78.53%	18,335 $257,000
Q2 2018 Aug 10, 2018	SELL	$13.44 - $17.59 $28,371 - $37,132	-2,111 Reduced 17.05%	10,270 $142,000
Q1 2018 May 14, 2018	BUY	$13.8 - $16.99 $170,857 - $210,353	12,381 New	12,381 $206,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.